NSG 552 Exam 3
Wilkes Psychopharmacology (2026)
125 Practice Questions
Main Features:
Comprehensive coverage of pharmacodynamics and kinetics.
Case-based clinical management scenarios.
Safety, priority, and patient education modules.
Detailed rationales for evidence-based practice.
,
,Instructions
This guide contains 125 original practice questions based on the Wilkes
Psychopharmacology framework. Utilize this for active recall and self-assessment. Each
question includes a rationale designed to reinforce clinical decision-making.
Question 1
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
Question 2
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
, Question 3
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
Question 4
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
Question 5
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
Wilkes Psychopharmacology (2026)
125 Practice Questions
Main Features:
Comprehensive coverage of pharmacodynamics and kinetics.
Case-based clinical management scenarios.
Safety, priority, and patient education modules.
Detailed rationales for evidence-based practice.
,
,Instructions
This guide contains 125 original practice questions based on the Wilkes
Psychopharmacology framework. Utilize this for active recall and self-assessment. Each
question includes a rationale designed to reinforce clinical decision-making.
Question 1
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
Question 2
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
, Question 3
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
Question 4
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
Question 5
Which of the following is the primary mechanism of action for SSRIs in the treatment of
major depressive disorder?
A. Inhibition of norepinephrine reuptake
B. Selective blockade of serotonin reuptake transporters
C. Antagonism of postsynaptic 5-HT2 receptors
D. Inhibition of monoamine oxidase enzymes
Correct Answer: B. Selective blockade of serotonin reuptake transporters
Rationale: SSRIs (Selective Serotonin Reuptake Inhibitors) work by blocking the reuptake of
serotonin into the presynaptic neuron, thereby increasing serotonin availability in the synaptic cleft.
